Fig. 1From: Hands on Alemtuzumab-experience from clinical practice: whom and how to treatComparison of different highly efficacious RRMS therapy strategies Alemtuzumab (right), and Natalizumab (left). The upper diagrams show the adverse effects, which happen usually within specific time windows, the lower diagrams the clinical efficacyBack to article page